NFL player Baker Mayfield caught using nicotine pouches on the field

Oct.23.2024

An American football player was seen using ZYN nicotine pouches during a game. Swedish Match reacted cautiously, emphasising that the product is only intended for consumers over the age of 21 and reminding young people not to imitate such behaviour.

American football player Baker Mayfield was caught using a ZYN nicotine pouch during the Monday Night Football game, according to TMZ Sports on 22 October. The manufacturer of the product, Swedish Match, reacted cautiously to the unexpected exposure.

A spokesperson for ZYN told TMZ Sports: "The company is very grateful for the support of loyal consumers, but also encourages users to ensure that the products are not in the presence of minors under the age of 21."

"This product is specifically marketed to nicotine users aged 21 and older as a better alternative to continued smoking and the use of other traditional tobacco products. However, "Monday Night Football" attracts a large audience every week and not all football fans are 21 years old.

In addition, the National Football League (NFL) policy specifically states that players may not use alcohol or tobacco products on the field or during interviews. Technically, this includes nicotine delivery devices such as ZYN.

Meadfield has not yet commented on the matter. The Swedish match manufacturer hopes that in the future no minors will imitate the player.

References:

[1] ZYN Urges Baker Mayfield To Not Use Nicotine Pouches On NFL Sidelines

Also Read:

[1] PMI reports strong Q3 performance: Smoke-free product users reach 36.5 million, ZYN sales up 41.4% in the US

[2] Seven & I Holdings to Close 444 North American Stores

[3] PMI Aims to Bring ZYN Nicotine Pouches to Germany and Accelerates Pod-Based E-Cigarette Rollout

[4] Tucker Carlson to launch nicotine pouch product “Alp”

[5] Maine Imposes 42% Tax Increase on Nicotine Pouches: The Price of Zyn is Soaring over 50%

[6] Undercover Operation Reveals Violations in Tobacco and E-Cigarette Sales

[7] The Rise of Nicotine Pouches: A Concerning Trend

[8] PMI Performance Report: ZYN Soars with 50.3% Surge in US Sales, Marking 4 Consecutive Quarters of Growth

[9] PMI to Build ZYN Nicotine Pouch Factory in Aurora, Colorado

[10] Zyn Faces Shortages and Subpoenas, Chinese Brands Swiftly Fill Market Gap

[11] NBC News: ZYN Shortage in US Sparks Frustration Among Nicotine Pouch Consumers

[12] National Movement to Save ZYN Nicotine Pouches Gains Momentum

#North America #United States #Regulation #Nicotine pouches

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

2Firsts Observation｜VELO at Stockholm Arlanda: Travel-Centric Messaging and Full-Line Flavour Presentation

2Firsts observed at Stockholm Arlanda Airport that British American Tobacco’s VELO positions the airport environment as a core marketing scenario, deploying large-format LED displays, a full flavour matrix, and clear nicotine-strength segmentation. The brand also features an instructional “How to Use VELO” section and multi-pack sales strategy, showcasing its systematic merchandising capabilities in the Nordic travel-retail channel.

Nov.19 by 2FIRSTS.ai

Russian Lawmaker Sounds Alarm as Teenage Vaping Surges—Female Use Overtakes Male

Russia’s Chair of the State Duma Committee on Youth Policy warns that among 11–14-year-olds, girls now vape at higher rates than boys, a trend he calls “deeply concerning.” He says the spread of nicotine products—especially e-cigarettes—among minors poses a public health risk and warrants continued policy-level interventions.

Oct.17 by 2FIRSTS.ai

Singapore tightens vape enforcement, mandates rehab for etomidate users

Singapore’s Ministry of Health (MOH) and Health Sciences Authority (HSA) reported that from Sep 1 to Oct 12, 1,339 people were caught for vape-related offences, including 102 found in possession of etomidate-laced vapes.

Oct.17 by 2FIRSTS.ai

FDA’s Makary on CNN: The Triple Challenge in Vape Regulation — New Opioids, Illicit Trade, and Youth Protection

In an interview with CNN’s Chasing Life, U.S. Food and Drug Administration (FDA) Commissioner Dr. Marty Makary warned that new health risks — from emerging opioids such as 7-OH to unregulated vaping products — are slipping through regulatory cracks. His remarks reveal the FDA’s growing challenge to balance harm reduction for adult smokers with youth protection and cross-border enforcement.